Previous close | 2.3000 |
Open | 2.2500 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 230.00 |
Expiry date | 2024-06-21 |
Day's range | 2.2500 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 126 |
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.